ReWalk机器人技术 RWLK 深 沪
已收盘 01-29 16:00:00 美东时间
1.0501
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 1.0501
- 总市值 6293.98万
- 52周最高 9.10
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 3.9228
- 委 比 0.00%
- 总股本 5993.70万
- 历史最高 7648.55
- 量 比 0
- 振 幅 0.00%
- 历史最低 2.87
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Administrative Law Judge Determines ReWalk Personal Exoskeleton is “Reasonable and Necessary” for Medicare Beneficiary
A recent ruling by an Administrative Law Judge (ALJ) has determined that the ReWalk Exoskeleton, developed by Lifeward Ltd., is a "reasonable and necessary" medical device for individuals with spinal cord injuries (SCI), allowing Medicare coverage for its use. This decision, which supports the medical necessity of the device, follows an April 2024 CMS ruling to finalize Medicare reimbursement for personal exoskeletons. The ReWalk Exoskeleton enab...
06-24 20:05
InspireMD appoints Michael Lawless CFO
InspireMD (NASDAQ:NSPR) announced on Tuesday the appointment of Michael Lawless as CFO, effective on or before June 30. Lawless is set to succeed Craig Shore. Most recently, Lawless served as the CFO ...
06-04 04:33
Lifeward appoints Mark Grant as CEO
Lifeward (NASDAQ:LFWD) announced on Monday that Mark Grant has been appointed as the company’s new president and chief executive officer, effective June 2, 2025. Larry Jasinski, Lifeward’s outgoing CE...
05-19 21:03
Lifeward Announces The U.S. National Launch Of The Rewalk 7 Personal Exoskeleton
Seventh generation of industry-leading personal exoskeleton is now available nationwide for individuals with spinal cord injuryNew and improved features streamline user experience for greater control, engagement, and
04-15 20:17
What's Going On With Lifeward Shares Thursday?
Lifeward stock is trading higher on Thursday after the company announced that its ReWalk 7 received 510(k) clearance from the Food and Drug Administration (FDA).
03-13 23:30
Lifeward gets FDA Clearance for its newest exoskeleton device
Lifeward (NASDAQ:LFWD) stock soared on Thursday after it has received 510((k)) FDA clearance for its new personal exoskeleton device, the ReWalk 7. LFWD is up 42% in morning trade. The company said t...
03-13 23:22
Lifeward Cancels Its Extraordinary General Meeting of Shareholders
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Jan. 13, 2025 (GLOBE NEWSWIRE) -- ...
01-13 20:45
Lifeward reports Q3 results; updates FY24 outlook
Lifeward press release (NASDAQ:LFWD): Q3 Non-GAAP EPS of -$0.45. Revenue of $6.1M (+39.2% Y/Y) misses by $2.34M. As of September 30, 2024, ReWalk had $10.7 million in unrestricted cash and cash equiv...
2024-11-12 21:07
繁荣的养老市场， 一套「行走的神器」爆红
随着国家一系列人口政策出台和落地，大众对老龄化进程有了越来越具体的感知。伴随着人口结构带来的紧迫感，应对老龄化的银发经济、老年健康产业迎来市场机遇。 智能技术作...
2024-10-10 08:20
Lifeward launches direct sales of AlterG product line in Germany
Lifeward (NASDAQ:LFWD) said on Tuesday that it will begin selling the AlterG family of products through its German sales organization, effective immediately. The move adds the AlterG product line to t...
2024-09-25 05:12
